Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in Kuwait

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorSulaiman Khadadah

About this trial

Lung cancer is a leading cause of cancer-related death in Kuwait, where most cases are diagnosed at an advanced stage and there is no national screening program. This prospective pilot feasibility study will offer low-dose computed tomography (LDCT) screening to approximately 500 high-risk individuals aged 50-80 years across Kuwait. The primary objective is to assess the uptake of, and barriers to, LDCT lung cancer screening in Kuwait and to establish a framework for a national screening program. Participants undergo eligibility assessment (smoking history of at least 20 pack-years, totalled across all tobacco products using pre-specified equivalency conversions for shisha/waterpipe, cigar, pipe, and roll-your-own tobacco), baseline assessment, LDCT screening with Lung-RADS-based management, a second screening round at 12 months, and follow-up. LDCT images are read by radiologists and in parallel by artificial intelligence (AI) software to evaluate AI-assisted reading. Findings will inform national lung cancer screening guidelines for Kuwait.

Eligibility criteria

Qualifiers

Age 50 to 80 years

Smoking history of at least 20 pack-years, totalled across all tobacco products using pre-specified equivalency conventions (1 shisha head-year = 1 pack-year; 1 cigar = 4 cigarettes; 1 pipe bowl = 2.5 cigarettes; roll-your-own tobacco 1 g = 1 cigarette). Current and former smokers are eligible regardless of time since quitting.

Able to provide informed consent

Disqualifiers

Previous diagnosis of lung cancer

Currently under surveillance for pulmonary nodules

Currently undergoing diagnostic assessment, treatment, or surveillance for major comorbidities

Unable to lie flat with arms raised above the head for CT scanning

Trial design

Treatments tested in this trial

  • Low-dose computed tomography (LDCT) lung cancer screening

Treatment groups

500 Participants
are divided into 1 treatment group

Sponsors and collaborators

Sulaiman Khadadah

Lead sponsor

Chest Diseases Hospital, Ministry of Health, Kuwait

Sponsor institution

Kuwait Foundation for the Advancement of Sciences

Collaborator

Ministry of Health, Kuwait

Collaborator